Third Circuit Affirms Denial of Preliminary Injunction in Samsung-Janssen Patent License Dispute
The Third Circuit upheld a district court's refusal to enjoin Samsung Bioepis from supplying a Cigna subsidiary with a private-label ustekinumab biosimilar, ruling that Johnson & Johnson and Janssen Biotech failed to...